A significant insider transaction involving the exercise of company stock options was reported on February 7, by Yin C Becker, VP at Stryker (NYSE:SYK), as per the latest SEC filing.
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday revealed that Becker, VP at Stryker in the Health Care sector, exercised stock options for 8,060 shares of SYK stock. The exercise price of the options was $93.06 per share.
Stryker shares are currently trading down by 0.0%, with a current price of $342.72 as of Thursday morning. This brings the total value of Becker's 8,060 shares to $2,012,259.
Get to Know Stryker Better
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Stryker: Financial Performance Dissected
Positive Revenue Trend: Examining Stryker's financials over 3 months ...